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Gap junctions are assemblies of intercellular channels that regulate a variety of physiologic and developmental
processes through the exchange of small ions and signaling molecules. These channels consist of connexin family
proteins that allow for diversity of channel composition and conductance properties. The human connexin 43 gene,
orGJA1, is located at human chromosome 6q22-q23 within the candidate region for the oculodentodigital dysplasia
locus. This autosomal dominant syndrome presents with craniofacial (ocular, nasal, and dental) and limb dys-
morphisms, spastic paraplegia, and neurodegeneration. Syndactyly type III and conductive deafness can occur in
some cases, and cardiac abnormalities are observed in rare instances. We found mutations in the GJA1 gene in all
17 families with oculodentodigital dysplasia that we screened. Sixteen different missense mutations and one codon
duplication were detected. These mutations may cause misassembly of channels or alter channel conduction prop-
erties. Expression patterns and phenotypic features of gja1 animal mutants, reported elsewhere, are compatible
with the pleiotropic clinical presentation of oculodentodigital dysplasia.
Introduction
Oculodentodigital dysplasia (ODDD [MIM *164200]),
also known as “oculodentoosseous dysplasia,” is an au-
tosomal dominant disorder with high penetrance, intra-
and interfamilial phenotypic variability, and advanced
paternal age in sporadic cases. To date, 170 reports in
the literature describe the clinical features of ODDD in
1240 patients, the majority of whom were white (Gorlin
et al. 2001; Loddenkemper et al. 2002). The typical cran-
iofacial anomalies include a thin nose with hypoplastic
alae nasi, small anteverted nares, prominent columnella,
and microcephaly (fig. 1). Brittle nails and hair abnor-
malities of hypotrichosis and slow growth are present.
Some cases have dysplastic ears and conductive hearing
loss. Ophthalmic findings include microphthalmia, mi-
crocornea, fine porous spongy iris abnormalities, cata-
racts, glaucoma, and optic atrophy. Anomalies observed
in the oral region are mandibular overgrowth and cleft
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palate. The majority of cases have abnormal primary
and permanent dentition with microdontia, partial an-
odontia, enamel hypoplasia, multiple caries, and early
tooth loss. Hand and foot abnormalities in ODDD in-
clude syndactyly involving the third, fourth, and fifth
fingers and second to fourth toes, camptodactyly, and
clinodactyly due to hypoplasia or aplasia of the middle
phalanges. Other skeletal abnormalities are cranial hy-
perostosis, mandible with wide alveolar ridge, and broad
tubular bones.
Neurologic symptoms are frequent in ODDD and in-
clude dysarthria, neurogenic bladder disturbances, spas-
tic paraparesis, ataxia, anterior tibial muscle weakness,
and seizures (Loddenkemper et al. 2002). Symptoms of
spastic bladder or gait disturbances are the usual pre-
senting neurologic manifestations evident by the 2nd
decade of life. Mild mental retardation occurs infre-
quently. Brain magnetic resonance imaging studies of
patients with ODDD have shown diffuse bilateral ab-
normalities in the subcortical cerebral white matter,
which can define a slowly progressive leukodystrophy.
The ODDD locus was mapped to chromosome 6q22-
q24 by linkage analysis (Gladwin et al. 1997), and the
location of the disease gene was further refined between
markers D6S266 and D6S1639 (Boyadjiev et al. 1999).
A detailed physical map with a YAC contig of the region
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Figure 1 ODDD phenotype. Across the top are an adult, a teenager, and a child with microcornea, narrow nose, and/or hypoplastic alae
nasi. Across the bottom are additional features: partial ano- and microdontia and enamel hypoplasia, syndactyly, and clinodactyly. The child’s
hand had surgical correction of the fourth and fifth finger syndactyly. Note that the child has a mild facial phenotype, but significant digital
involvement, as shown in the bottom two right panels. The individuals in the top and bottom left panels are brothers with the Y17S mutation.
The teenager has a G22E mutation, and the child has an Y98C mutation.
was created and fourteen candidate genes were identi-
fied and excluded by mutation analysis (Boyadjiev et
al., in press; unpublished data). Another gene in the
region is GJA1, which encodes gap junction protein
alpha 1, a member of a large family of homologous
connexin proteins.
GJA1 or connexin 43, like other connexin proteins,
consists of an intracellular N-terminus, four transmem-
brane domains, two extracellular loops, one cytoplas-
mic loop, and an intracellular C-terminus (Kelsell et al.
2001). Six connexins can form a connexon, a specialized
intracellular structure surrounding a pore. Two con-
nexons in apposing cell membranes can align to form
an intercellular gap junction. These channels provide a
direct low-resistance intercellular pathway for the pas-
sage of ions and small molecules that confer distinct
physiological properties. Gap junctions have been found
in the majority of mammalian tissues. Most tissues ex-
press more than one type of connexin, and multiple
types of connexins can assemble to form gap junctions
between cells, with the diversity of combinations influ-
encing the nature of the cell-to-cell communication.
These properties are important for many physiological
and developmental processes.
In mouse embryogenesis, Gja1 is expressed, beginning
at the blastocyst stage, in discrete spatially restricted do-
mains in the developing brain, neural tube, prevertebrae,
and limb, and in various aspects of organogenesis (Ru-
angvoravat and Lo 1992). Its expression is associated
with developmental processes mediated by inductive in-
teractions, involving the branchial arches, eye, and otic
vesicle, as well as migratory cells of the neural crest and
sclerotomes. In postnatal tooth development, rat con-
nexin 43 is demonstrated between the odontoblasts that
actively secrete dentin matrix (Murakami et al. 2001),
and its expression is seen in the epithelial-derived ame-
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loblasts synthesizing and secreting enamel matrix pro-
teins (Fried et al. 1996). A BLASTn search of the NCBI
human est database, using the GJA1 mRNA sequence
NM_000165, revealed GJA1 expression in libraries de-
rived from placenta, brain, nerve, thyroid, lung epithelial
cells, bone, bone marrow, testis, uterus, skin, and duo-
denal adenocarcinoma.
Despite the near-ubiquitous expression of the con-
nexins, previous disorders associated with mutations in
various connexins have a restricted range of phenotypic
abnormalities, isolated deafness, skin abnormalities
with or without deafness, or peripheral neuropathy. The
human GJA1 gene is a candidate gene for the pleiotropic
condition ODDD because of its map location and wide
expression pattern. In this study, we screened the can-
didate geneGJA1 for mutations in families affected with
ODDD.
Patients and Methods
We recruited seventeen unrelated white families affected
with ODDD, with a total of 60 family members ranging
in age from 2 wk to adulthood. All affected individuals
had the typical ODDD craniofacial appearance and limb
involvement. Members of nine of these families had neu-
rologic manifestations. We obtained informed consent
(protocol approved by the institutional review board of
Johns Hopkins University) from all participants who un-
derwent physical examination, photo documentation,
and sample collection. DNA was isolated from patients’
blood samples or Epstein Barr virus–transformed lym-
phoblastoid cell lines. Centre d’Etude du Polymorphisme
Humain (CEPH) DNAs were used as controls.
The organization of the GJA1 gene was determined
from the human chromosome 6 sequence (map element
NT_033944.2 in NCBI Sequence Viewer). The gene is
composed of two exons with an intervening intron 11
kb in size. The mRNA sequence (NM_000165 or
XM_027459) contains 191 bp of the first exon, which
is untranslated. The second exon consists of 16 bp of
additional 5′ untranslated sequence, 1,149 bp of coding
sequence, and ∼1,732 bp of 3′ untranslated sequence.
There are two potential poly (A) signal sites in the 3′
UTR at nucleotides 1759–1764 and at 3062–3067 of
NM_000165 with the latter being utilized. There is a
GJA1 pseudogene, GJA1P1, located within chromo-
some 5 at 5q21-5q22 (map element NT_006654.9).
PCR primers were designed with mismatches to the
pseudogene sequence to specifically amplify GJA1 and
avoid amplification of GJA1P1. A 925-bp product,
which contains the coding sequence for the first 238
amino acids of the GJA1 protein, was amplified with
forward primer 5′-GATCTTTTCTTCGTTGGC-3′ (with-
in intron 1) and reverse primer 5′-CTCTTTCCCTTAAC-
CCG-3′. A 1,079-bp product, which contains the coding
region for the latter 178 amino acids of the GJA1 protein
and extends into the 3′ UTR, was amplified with forward
primer 5′-TTCCTCTCTCGCCCCAC-3′ and reverse
primer 5′-GGCCTAGAAAGCTTACCTT-3′. Conditions
of amplification were determined on a Bio-Rad Labo-
ratories iCycler. All amplifications were performed using
Platinum Taq High Fidelity DNA polymerase (Invitro-
gen). PCR products were sequenced in the forward and
reverse directions by the dideoxy chain termination
method on an ABI Prism 3700 automated fluorescent
DNA analyzer (Applied Biosystems).
Six rare polymorphisms were observed within the
100 control alleles examined: IVS1-65G/A (1% inci-
dence), IVS1-12T/A (1%), 717G/A (2%), 758C/T (1%),
11152_1153insA (2%), and 1322G/A (3%). Two of
these were within the coding region, one resulting in a
synonymous change, R239R (CGGrCGA), and the
other resulting in A253V (GCGrGTG). The polymor-
phic amino acid change within the C-terminal domain,
A253V, seen in one control allele, occurred in an amino
acid that is not conserved among the GJA1 proteins of
various species or among the human connexins. It should
be noted that most of the variations listed in the GJA1
mRNA entry NM_000165 between nucleotides 160–
1384 can be accounted for by nucleotide differences be-
tween GJA1 and its pseudogene and are not polymor-
phisms within GJA1.
Results and Discussion
GJA1 Mutations
We found mutations in 100% of the individuals stud-
ied who were affected with ODDD (table 1; fig. 2). A
different missense mutation was found for each family,
with the exception of a codon duplication in one family.
These mutations segregated with the disease and were
not found in any unaffected family members or in 100
control alleles from white subjects. The presence of dif-
ferent mutations in each family provides evidence that
ODDD did not arise from a founder effect in the white
population.
These amino acid changes are distributed throughout
the protein, with the majority occurring in the amino
terminal half (table 1; fig. 3). Mutations that produced
pronounced changes—on the basis of differences in
amino acid size and charge and lack of conservation
among the connexins—are present in the cytoplasmic
(Y17S, Y98C, I130T, and G138R), transmembrane
(G21R and G22E), and extracellular (R76S) domains.
Each mutation affects an amino acid highly conserved
among the connexin 43 protein sequences for various
species (fig. 4). Additionally, many of these same amino
acids are conserved among the human connexin protein
family, which are expressed from at least 20 different
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Table 1
GJA1 Mutations in ODDD
Family/Case Inheritancea
Nucleotide
Changeb
Amino Acid
Changeb Reference(s)c
FOD1118-4881 F* 50A1C Y17S Rajic and deVeber 1966; Boyadjiev et al. 1999
FOD1120-1902 F* 52T1C S18P Zellweger and Ionasescu 1974; Zach 1975; Judisch et al. 1979
FODMS2630 S* 61G1A G21R This report
FODHN2441 S 65G1A G22E Traboulsi and Parks 1990
FOD1083-4795 S 68A1C K23T Gorlin et al. 1963
FODCL2603 S* 119C1T A40V This report
FODJC1858 F* 145C1A Q49K Boyadjiev et al. 1999
FODLM1899 F 154_156dupTTT F52dup Gellis and Feingold 1974; Weintraub et al. 1975
FOD1113-4855 F* 226C1A R76S Stanislaw et al. 1998; Boyadjiev et al. 1999
FOD1140-4922 F* 268C1G L90V Mohr 1939; Opjordsmoen and Nyberg-Hansen 1980; Boyad-
jiev et al. 1999
FOD1119-4896 F* 293A1G Y98C Wooldridge et al. 1977; Wooldridge 1993; Boyadjiev et al.
1999
FODBC36590 F* 306G1C K102N This report
FODRB2514 F 389T1C I130T This report
FODOK2770 S 400A1G K134E This report
FOD975-4595 F* 412G1C G138R Shapiro et al. 1997; Boyadjiev et al. 1999
FODHB00-153-0388 F* 605G1A R202H This report
FODJS2375 F 646G1T V216L Norton et al. 1995; Boyadjiev et al. 1999
a F p familial; S p sporadic. An asterisk (*) denotes that more than one sample was available to document, in multiplex families,
segregation of the mutation or, in sporadic cases, the absence of the mutation in both parents.
b Mutation nomenclature is according to den Dunnen and Antonarakis (2000).
c References are for families previously reported with clinical description or who have participated in linkage studies.
genes. Several of the amino acid alterations occur at the
same residues that are mutated in other connexin (26,
31, and 32) disorders (table 2). The phenotypes do not
correlate between those generated by connexin 43 mu-
tations and by analogous amino acid mutations in other
connexins. Multiple connexin 26 and 32 mutations in
amino acids corresponding to connexin 43 R76 and
R202 result in more than one phenotype.
Major Phenotypic Features (Syndactyly and
Neurodegeneration) and GJA1 Genotype Analysis
Our mutation analysis supports clinical observations
that ODDD is fully penetrant, since all carriers of mu-
tations exhibited craniofacial and limb dysmorphisms. In-
trafamilial variability of the major phenotypic character-
istics was observed for all mutations segregating in
multiplex families. For example, all of our probands have
syndactyly involving at least the fourth and fifth fingers.
Four individuals with sporadic disease have syndactyly
type III (involvement of only the fourth and fifth fingers)
and different missense mutations in the first transmem-
brane domain (G21R, G22E, K23T, and A40V). Two of
our multiplex families have a proband with syndactyly
type III but have other affected family members with ad-
ditional digital involvement and mutations in domains
beyond the first transmembrane (F52dup and R202H).
These data suggest, as already stated in the literature, that
ODDD and “isolated” syndactyly type III (MIM 186100)
may represent a disease spectrum rather than separate
genetic conditions (Schrander-Stumpel et al. 1993). The
association of GJA1 mutations with abnormal limb de-
velopment can be inferred by the strong expression of
connexin 43 in the distal part of early limb buds and its
restricted pattern in the developing digits and regions of
precartilage condensation, as shown in Xenopus laevis,
mouse, and chick (Ruangvoravat and Lo 1992; Meyers
et al. 1997; van der Heyden et al. 2001).
It should also be noted from our data that specific
phenotypic characteristics of ODDD did not appear to
segregate with mutation(s) in specific protein domain(s).
Thus, no obvious phenotype-genotype correlations were
noted. As an example, nine of our families with neu-
rologic symptoms, including five with documented
white-matter degeneration, have mutations distributed
in the N-terminal, membrane and intracellular domains
(Y17S, G22E, K23T, L90V, K102N, I130T, K134E,
G138R, and V216L). Epilepsy, which has been observed
previously in ODDD, is present in two of our case sub-
jects with the mutations R76S in the first extracellular
loop and L90V in the second transmembrane domain.
Two individuals with sporadic cases of ODDD and with
G21R and A40V mutations do not manifest neurologic
symptoms but are !2 years of age. It is of note that no
neurologic symptoms were present among all affected
adults in five of our affected families (S18P, Q49K,
F52dup, Y98C, and R202H). Mutations in GJB1 (con-
nexin 32), the major connexin of myelin-forming
Schwann cells result in X-linked Charcot-Marie-Tooth
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Figure 2 Sequences of 17 GJA1 mutations found in families affected with ODDD. The top panels show the heterozygous mutations,
with the exception of the sequence of the cloned duplication, 154_156dupTTT, and the bottom panels show the control sequences.
disease (MIM 302800), a congenital demyelinating dis-
order of peripheral nerve (Bergoffen et al. 1993; Ressot
and Bruzzone 2000). The type of degeneration in this
disease differs from ODDD, since it involves myelin of
peripheral nerves rather than myelin of the CNS.
In the CNS, connexin 43 is the major connexin of
astrocytes and ependymocytes but is not expressed in
oligodendrocytes or neurons. The role of connexin 43
in astrocyte gap junctions is not well understood, but
they have been implicated in the propagation of cortical
“calcium waves” and “spreading depression” (Martins-
Ferrerira et al. 2000), and epilepsy is associated with
cortical astrocytes with increased gap junction coupling
(Lee et al. 1995). Astrocytes may also express limited
quantities of other connexins, such as connexins 26, 30,
and 45 (Dermietzel et al. 2000). Myelin-forming oli-
godendrocytes predominantly express connexin 32 but
may also express connexin 45 (Dermietzel et al. 1997).
Although astrocytes or oligodendrocytes form gap junc-
tions with themselves, astrocytic-oligodendroglial gap
junctions are also observed. The latter junctions may
result from several possible heterotypic pairings, includ-
ing connexin 43 with connexin 45 (Rash et al. 2001).
Aberrant heterotypic pairings may be a molecular ex-
planation of how mutations in connexin 43, which is
normally expressed in astrocytes but not in oligoden-
droglial cells, can contribute to the dysfunction of CNS
myelin observed in ODDD leukodystrophy.
Additional Phenotypic Features (Conductive Hearing
Loss, Cataracts, Glaucoma, Keratoderma, and Cardiac
Defects) and GJA1 Genotype Analysis
Eight of our families affected with ODDD have con-
ductive hearing loss and mutations located in the N-
terminal, transmembrane, and cytoplasmic loop regions
(Y17S, S18P, G22E, K23T, L90V, Y98C, G138R, and
V216L). GJA1 and other connexins are expressed in the
cochlea (Rabionet et al. 2000), and mutations in other
connexin proteins (connexin 32, 26, 31, and 30) have
been associated with both autosomal dominant and au-
tosomal recessive nonsyndromic hearing impairment,
usually sensorineural. The type of hearing impairment
in ODDD differs from the typical hearing loss associated
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Figure 3 Diagram of the GJA1 protein. Locations of the amino acid changes are shown. The first and last amino acids of the protein
and of each transmembrane domain are indicated as predicted by the program TMpred (see the TMpred Web site).
with other connexin mutations, because it is conductive
rather than sensorineural. Lui and his colleagues (2001)
reported L11F and V24A mutations in connexin 43 in
association with sensorineural recessive deafness. How-
ever, these mutations have subsequently been shown to
involve the pseudogene of connexin 43 on chromosome
5 (W. E. Nance, personal communication).
One familial case had cataracts and the Y17S muta-
tion. In the literature, there are mutations in GJA3 and
GJA8 (connexins 46 and 50) that are found in patients
with dominant zonular pulverulent cataracts (Shiels et
al. 1998; Mackay et al. 1999). Glaucoma presented in
this same individual with the Y17S mutation and in two
other case individuals with G22E and L90V mutations.
Connexin 43 plays an important role in eye develop-
ment. It is expressed in the lens placode and during fetal
stages in the anterior and lateral lens epithelium in the
mouse, sheep, and chick (White 2002). Other connexins
including connexin 46 and 50 are also expressed in the
developing lens. In connexin 50 knockout mice, White
et al. (1998) demonstrated that there was little if any
prenatal effect, but postnatally two ocular abnormalities
were present—microphthalmia and pulverulent cata-
racts. Similar features have been observed in ODDD
patients. Connexin 43 is also localized in the outer pig-
mented cell layer of the ciliary body and pairs to the
nonpigmented cell layer to form heterotypic junctions
(Vaney et al. 2000). Glaucoma can result from an im-
balance in intraocular fluid production by the ciliary
body and outflow through the trabecular meshwork.
Since connexin 43 deficient mice fail to thrive past birth,
it can only be postulated that connexin 43 deletion or
another type of mutation may unbalance connexin di-
versity and result postnatally in cataracts and glaucoma.
Some of our patients with ODDD exhibited pheno-
typic features rarely associated or not previously de-
scribed for this condition. Two members of the family
with the F52dup mutation had cleft palate. A familial
case with the K102N mutation had plagiocephaly with
no synostosis. One individual with sporadic ODDD had
hyperkeratosis of the palms and soles and the K134E
mutation. It is of interest that missense mutations in
GJB2 (connexin 26) have been implicated in other skin
conditions: palmar and plantar keratoderma with sen-
sorineural deafness (Richard et al. 1998a), Vohwinkel
syndrome (keratoderma, constriction of the digits, and
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Figure 4 Amino acid conservation in connexins. The amino acids of GJA1 that are affected in ODDD are aligned to the corresponding
amino acids in gja1 in other species and in other human connexins. Accession numbers given (from NCBI’s Entrez-Protein Web site) are for
the versions used in the alignment. Connexin amino acid alignments were performed using the ClustalW program (see ClustalW Web site).
Proteins are ordered according to homology. Gray shading indicates amino acid differences from the human GJA1 protein. Darker shading
indicate amino acids observed only once in the connexins.
sensorineural deafness) (Maestrini et al. 1999), and
KIDS (keratitis, ichthyosis, and sensorineural deafness)
(Richard et al. 2002). Mutations in GJB3 and GJB4
(connexin 31 and 30.3) can cause erythrokeratodermia
variabilis (Richard et al. 1998b; Macari et al. 2000), and
mutations in GJB6 (connexin 30) are present in patients
with hidrotic ectodermal dysplasia (Lamartine et al.
2000).
Two of our families with ODDD had cardiac abnor-
malities. One individual with sporadic ODDD who had
the G21R mutation had an atrioseptal defect. In addi-
tion, a familial case had recurrent ventricular tachycar-
dia and an atrioventricular block with the I130T mu-
tation. The latter proband’s paternal grandmother and
father both died at 43 years of age, from cardiac ar-
rhythmia and sudden cardiac death, respectively. Two
paternal aunts have ventricular tachycardia and sick si-
nus syndrome. The proband and father have craniofacial
features of ODDD. Although some of the family mem-
bers with cardiac findings do not present with the cran-
iofacial features of ODDD, they have not been screened
for the mutation. The presence of congenital heart dis-
ease in ODDD has been noted previously. Schneider et
al. (1977) reported a patient with an endocardial cush-
ion defect, ostium primum atrial septal defect with a
cleft mitral valve, which may result from a conotruncal
heart defect. In addition, a heart murmur attributed to
a ventricular septal defect was reported in an ODDD
patient (Judisch et al. 1979).
The results of molecular studies are not clear as to the
role that GJA1 mutations, rare or mosaic, may play in
human cardiac malformations such as visceroatrial het-
erotaxia (Britz-Cunningham et al. 1995) and hypoplastic
left heart (Dasgupta et al. 2001). However, it should be
noted that a major site of expression of connexin 43 in
mammals is cardiac muscle, where other connexins (37,
40, and 45) are also expressed (Kanter et al. 1993).
Connexin 43 expression is not detected in the heart of
day 8.5 mouse embryos, but it is quite prominent in the
ventricle by day 10.5. Transgenic mice containing a cy-
tomegalovirus (CMV) promoter driven connexin 43
construct caused Gja1 overexpression and conotruncal
heart, right ventricle, pulmonary outflow tract, coronary
vasculature, and neural tube defects (Ewart et al. 1997).
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Table 2
Connexin Mutations in Conserved Amino Acids
Protein Mutations Phenotype Reference
GJA1 (Cx43) S18P G22E A40V R76S L90V K134E R202H ODDD This report
GJB2 (Cx26) S17F KIDS Richard et al. 2002
GJB2 (Cx26) R75W ADN-SHI and PPK Richard et al. 1998a
GJB2 (Cx26) R75Q ADN-SHI Connexin-Deafness Home Page
GJB2 (Cx26) K122I ARN-SSNHI Connexin-Deafness Home Page
GJB2 (Cx26) R184Q ADN-SSNHI Connexin-Deafness Home Page
GJB2 (Cx26) R184P ARN-SHI, compound heterozygote
with delE138
Connexin-Deafness Home Page
GJB2 (Cx26) R184W ARN-SHI, compound heterozygote
with M34T
Connexin-Deafness Home Page
GJB3 (Cx31) R180X ADN-SHI Connexin-Deafness Home Page
GJB1 (Cx32) L89V ADHI Connexin-Deafness Home Page
GJB1 (Cx32) G21D A39P R75P L89P R183C CMT1X CMT Mutations by Gene Web site
GJB1 (Cx32) R75Q R183H CMT1X CMT Mutations by Gene Web site
GJB1 (Cx32) R183S CMT1X CMT Mutations by Gene Web site
GJB1 (Cx32) R75W CMT1X and 48,XXYY CMT Mutations by Gene Web site
GJB1 (Cx32) A39V CMT1X and CNS involvement CMT Mutations by Gene Web site
NOTE.—AD p autosomal dominant; AR p autosomal recessive; N-S p nonsyndromic; SN p sensorineural; HI p hearing impairment; PPKp palmoplantar
keratoderma; CMTX1 p X-linked Charcot-Marie-Tooth syndrome.
The developmental abnormalities in the coronary vas-
culature are consistent with neural crest involvement,
since deployment of the coronary vessels is dependent
on neural crest–derived parasympathetic innervation in
the heart. The Purkinje conduction fibers codistribute
with the formation of coronary vasculature in avian em-
bryos (Gourdie et al. 1995). Connexin 43 heterozygous
knockout mice bred with connexin 40 null mice to yield
haploinsufficiency of both genes show additive effects
on ventricular (not atrial) conduction and cardiac mor-
phogenesis of hypertrophy, in conjunction with atrio-
ventricular junction or ventricular septal defects (Kirch-
hoff et al. 2000). The detection of the conduction system
abnormalities in one of our families with ODDD may
be consistent with altered expression of connexin 43. It
is less clear whether the septal defect found in the other
ODDD case mentioned above is directly related to con-
nexin 43 dysfunction.
It was hypothesized that ODDD displayed the phe-
nomenon of genetic anticipation (Shapiro et al. 1997).
At least four ODDD families in the literature showed
increasing severity of neurologic symptoms—such as
white matter changes of the brain, spastic bladder, spas-
tic paraplegia, and ataxia—in subsequent generations.
Three families have shown more involvement of dys-
morphic features, particularly syndactyly, in successive
generations. However, mutation analysis of four of these
families revealed changes (S18P, L90V, Y98C, and
G138R) that cannot account for the genetic anticipation.
Although unlikely, additional changes might be observed
in the noncoding regions, which we did not screen,
where many of the repeated trinucleotide sequences have
been found for other disorders showing genetic antici-
pation. It is more likely that there are genetic and en-
vironmental modifiers that can account for the “ob-
served” anticipation.
Relevance of Gja1 Null Mouse
Features observed in connexin 43 knockout mice are
relevant but do not mimic the craniofacial, limb, or car-
diac findings associated with ODDD. The lack of phe-
notypic correlation between the knockout mouse and
ODDD suggests that loss of function of connexin 43 is
not the mechanism by which missense mutations cause
the human phenotype. For example, connexin 43 is the
major gap junction protein present in osteoblasts (Civ-
itelli et al. 1993). Lecanda et al. (2000) determined that,
during embryonic development of connexin 43 null mu-
tant mice, generalized intramembraneous and endoch-
rondral bone development was delayed as a result of
osteoblast dysfunction. At birth, these mice exhibited
ossification defects of the skull, originating from hy-
poplastic, migratory neural crest cells, and mineraliza-
tion defects in non–neural crest–derived bone. The man-
dible was small, with a rounded alveolar ridge and
flattened arch that resulted in the development of small
and pointed snouts and less prominent incisors. These
features suggest that connexin 43 affects craniofacial de-
velopment and normal osteogenesis, which is compatible
with the ODDD phenotype. However, the craniofacial
features are not consistent with those of ODDD, and
limb abnormalities are lacking in the null mouse
(Reaume et al. 1995; Lecanda et al. 2000). Furthermore,
cardiac malformations involving blockage of the right
ventricular outflow tract, present in the null mice
(Reaume et al. 1995; Guerrero et al. 1997), are not ob-
vious in the ODDD phenotype.
Potential Functional Consequences of Mutant GJA1
Mutations in the connexins can have variable func-
tional consequences, which explains how mutations in
different connexins or different mutations in the same
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connexin can cause an isolated or pleiotropic phenotype.
In general, the deletion of one copy of a connexin gene
does not appear to be of major consequence, as can be
seen in animal-model knockouts as well as in human
conditions that are recessive in nature. Deletion of both
copies will be of consequence in cells and tissues where
this connexin is vital and/or there is a lack of other
connexins of compensatory function. In the case of mis-
sense mutations, cellular function of gap junctions may
be affected in a number of ways. One possibility is that
the protein alteration may cause mislocation to the cy-
toplasm and, for recessive mutations, failure to form
connexons (either homotypic or of the appropriate het-
erotypic composition). Other protein alterations may al-
low mutant connexon formation, yet may disallow the
formation of gap junctions with connexons of other
cells. Lastly, some alterations may allow complete gap
junctions to form across cells, but their properties of
conductance, molecular permeability, phosphorylation,
and voltage gating are significantly altered, and cellular
function is affected either as a dominant negative or gain
of function. In this regard, it is notable that five ODDD
missense mutations (Y17S, S18P, G21R, G22E, and
K23T) are clustered within a region homologous to a
calmodulin-binding motif of connexin 32 (Peracchia et
al. 2000). Gating of gap junctions by calmodulin is be-
lieved to occur in response to changes in intracellular
calcium.
Pal et al. (1999) demonstrated that a connexin 50
mutation, P88S, failed to form functional gap junctions,
as measured by conductance in Xenopus oocytes, when
paired homotypically, and was able to inhibit the func-
tional form of wild type connexin 50 in a dose-depen-
dent fashion; Pal et al. concluded that only one mutant
subunit per gap junction was necessary to abolish chan-
nel function. Richard et al. (1998a) had previously
shown that the connexin 26 autosomal dominant mu-
tation R75W (analogous to connexin 43 residue R76,
which is mutated to a serine in ODDD) (table 2) also
acted in a dominant-negative fashion against wild-type
connexin 26; however, the autosomal recessive mutant
W77R, though failing to form functional gap junctions
itself, did not greatly interfere with wild-type connexin
as measured by conductance in Xenopus oocytes. Rouan
et al. (2001) further demonstrated trans-dominant in-
hibition of connexin 43 by mutant connexin 26 in Xen-
opus oocytes. Richard et al. (2002) showed lack of cou-
pling and dye transfer in HeLa cells expressing mutant
connexin 26 S17F (analogous to connexin 43 residue
S18, which is mutated to a proline in ODDD) (table 2)
and proposed a trans-dominant inhibition of connexin
30.
One can, then, speculate that the GJA1 missense mu-
tations found in ODDD have a dominant negative effect.
A single hit that alters the function of the mutant allele
causes the pleiotropic phenotype of ODDD because of
the wide expression pattern of GJA1, and this allele may
then cause aberrant connexons with the wild-type allele
and other connexins. However, we cannot exclude the
possibility that these missense mutations result in gain
of function. Additionally, there must be modifiers, per-
haps in different racial groups that enhance the degree
of pleiotropy and variability of expression observed in
ODDD. The complex combinatorial interactions among
the connexins suggest that additional mutational anal-
ysis of connexins other than connexin 43 in ODDD pa-
tients may give us insights into which specific connexins
may modify the functional consequences of the GJA1
missense mutations. Also, future studies usingGJA1 site-
directed mutagenesis in combination with other normal
or mutant connexins in cellular and animal model sys-
tems will shed light on how the observed missense mu-
tations contribute to the pathogenesis of ODDD.
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